{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:54:22Z","timestamp":1790996062957,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100013772","name":"SENS Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01822-7","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:34:28Z","timestamp":1753518868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A human neuron Alzheimer\u2019s disease model reveals barriers to senolytic translatability"],"prefix":"10.1186","volume":"17","author":[{"given":"Chaska C.","family":"Walton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suckwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Siebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Bergo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Mayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","volume":"38","author":"J Cummings","year":"2024","unstructured":"Cummings J, Osse AML, Cammann D, Powell J, Chen J. Anti-Amyloid monoclonal antibodies for the treatment of alzheimer\u2019s disease. BioDrugs. 2024;38:5\u201322.","journal-title":"BioDrugs"},{"key":"1822_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, et al. Lecanemab in early alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"1822_CR3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, et al. Donanemab in early alzheimer\u2019s disease. N Engl J Med. 2021;384:1691\u2013704.","journal-title":"N Engl J Med"},{"key":"1822_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, et al. The antibody aducanumab reduces A\u03b2 plaques in alzheimer\u2019s disease. Nature. 2016;537:50\u20136.","journal-title":"Nature"},{"key":"1822_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nrd4793","volume":"14","author":"AS Kesselheim","year":"2015","unstructured":"Kesselheim AS, Hwang TJ, Franklin JM. Two decades of new drug development for central nervous system disorders. Nat Rev Drug Discovery. 2015;14:815\u20136.","journal-title":"Nat Rev Drug Discovery"},{"key":"1822_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/nyas.12417","volume":"1313","author":"TJ Scott","year":"2014","unstructured":"Scott TJ, O\u2019Connor AC, Link AN, Beaulieu TJ. Economic analysis of opportunities to accelerate alzheimer\u2019s disease research and development. Ann N Y Acad Sci. 2014;1313:17\u201334.","journal-title":"Ann N Y Acad Sci"},{"key":"1822_CR7","doi-asserted-by":"publisher","first-page":"172524","DOI":"10.1016\/j.ejphar.2019.172524","volume":"859","author":"DH Veening-Griffioen","year":"2019","unstructured":"Veening-Griffioen DH, et al. Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for alzheimer\u2019s disease. Eur J Pharmacol. 2019;859:172524.","journal-title":"Eur J Pharmacol"},{"key":"1822_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-024-01033-z","volume":"23","author":"M Riessland","year":"2024","unstructured":"Riessland M, Ximerakis M, Jarjour AA, Zhang B, Orr ME. Therapeutic targeting of senescent cells in the CNS. Nat Rev Drug Discov. 2024;23:817\u201337.","journal-title":"Nat Rev Drug Discov"},{"key":"1822_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"J-P Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 J-P, Desprez P-Y, Krtolica A, Campisi J. The Senescence-Associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"key":"1822_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813\u201327.","journal-title":"Cell"},{"key":"1822_CR11","doi-asserted-by":"publisher","first-page":"e12840","DOI":"10.1111\/acel.12840","volume":"17","author":"N Musi","year":"2018","unstructured":"Musi N, et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell. 2018;17:e12840.","journal-title":"Aging Cell"},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian TJ, et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018;562:578\u201382.","journal-title":"Nature"},{"key":"1822_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an alzheimer\u2019s disease model. Nat Neurosci. 2019;22:719\u201328.","journal-title":"Nat Neurosci"},{"key":"1822_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.celrep.2017.12.092","volume":"22","author":"SJ Chinta","year":"2018","unstructured":"Chinta SJ, et al. Cellular senescence is induced by the environmental neurotoxin Paraquat and contributes to neuropathology linked to parkinson\u2019s disease. Cell Rep. 2018;22:930\u201340.","journal-title":"Cell Rep"},{"key":"1822_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288:518\u201336.","journal-title":"J Intern Med"},{"key":"1822_CR16","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3233\/JAD-230465","volume":"97","author":"PY Ng","year":"2024","unstructured":"Ng PY, Zhang C, Li H, Baker DJ. Senescence targeting methods impact alzheimer\u2019s disease features in 3xTg mice. J Alzheimers Dis. 2024;97:1751\u201363.","journal-title":"J Alzheimers Dis"},{"key":"1822_CR17","doi-asserted-by":"publisher","first-page":"106711","DOI":"10.1016\/j.nbd.2024.106711","volume":"202","author":"M Yao","year":"2024","unstructured":"Yao M, et al. Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model. Neurobiol Dis. 2024;202:106711.","journal-title":"Neurobiol Dis"},{"key":"1822_CR18","doi-asserted-by":"publisher","first-page":"111585","DOI":"10.1016\/j.mad.2021.111585","volume":"200","author":"S Lee","year":"2021","unstructured":"Lee S, et al. A guide to senolytic intervention in neurodegenerative disease. Mech Ageing Dev. 2021;200:111585.","journal-title":"Mech Ageing Dev"},{"key":"1822_CR19","doi-asserted-by":"publisher","first-page":"1434945","DOI":"10.3389\/fnins.2024.1434945","volume":"18","author":"S Fernandes","year":"2024","unstructured":"Fernandes S, et al. Modeling alzheimer\u2019s disease using human cell derived brain organoids and 3D models. Front NeuroSci. 2024;18:1434945.","journal-title":"Front NeuroSci"},{"key":"1822_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","volume":"25","author":"J Penney","year":"2020","unstructured":"Penney J, Ralvenius WT, Tsai L-H. Modeling alzheimer\u2019s disease with iPSC-derived brain cells. Mol Psychiatry. 2020;25:148\u201367.","journal-title":"Mol Psychiatry"},{"key":"1822_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.nbd.2004.09.002","volume":"18","author":"K Walsh","year":"2005","unstructured":"Walsh K, Megyesi J, Hammond R. Human central nervous system tissue culture: a historical review and examination of recent advances. Neurobiol Dis. 2005;18:2\u201318.","journal-title":"Neurobiol Dis"},{"key":"1822_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0896-6273(95)90232-5","volume":"14","author":"J Busciglio","year":"1995","unstructured":"Busciglio J, Lorenzo A, Yeh J, Yankner B. A. beta-amyloid fibrils induce Tau phosphorylation and loss of microtubule binding. Neuron. 1995;14:879\u201388.","journal-title":"Neuron"},{"key":"1822_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/361260a0","volume":"361","author":"P Seubert","year":"1993","unstructured":"Seubert P, et al. Secretion of \u03b2-amyloid precursor protein cleaved at the amino terminus of the \u03b2-amyloid peptide. Nature. 1993;361:260\u20133.","journal-title":"Nature"},{"key":"1822_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/359325a0","volume":"359","author":"P Seubert","year":"1992","unstructured":"Seubert P, et al. Isolation and quantification of soluble alzheimer\u2019s \u03b2-peptide from biological fluids. Nature. 1992;359:325\u20137.","journal-title":"Nature"},{"key":"1822_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1471-4159.2001.00012.x","volume":"76","author":"HF Dovey","year":"2001","unstructured":"Dovey HF, et al. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem. 2001;76:173\u201381.","journal-title":"J Neurochem"},{"key":"1822_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","volume":"12","author":"MP Mattson","year":"1992","unstructured":"Mattson MP, et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci. 1992;12:376\u201389.","journal-title":"J Neurosci"},{"key":"1822_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1083\/jcb.200110119","volume":"156","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, McLaughlin R, Goodyer C, LeBlanc A. Selective cytotoxicity of intracellular amyloid \u03b2 peptide1\u201342 through p53 and Bax in cultured primary human neurons. J Cell Biol. 2002;156:519\u201329.","journal-title":"J Cell Biol"},{"key":"1822_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neulet.2009.07.031","volume":"462","author":"J-F Hou","year":"2009","unstructured":"Hou J-F, Cui J, Yu L-C, Zhang Y. Intracellular amyloid induces impairments on electrophysiological properties of cultured human neurons. Neurosci Lett. 2009;462:294\u20139.","journal-title":"Neurosci Lett"},{"key":"1822_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0165-0270(02)00126-7","volume":"118","author":"RR Hammond","year":"2002","unstructured":"Hammond RR, et al. A reliable primary human CNS culture protocol for morphological studies of dendritic and synaptic elements. J Neurosci Methods. 2002;118:189\u201398.","journal-title":"J Neurosci Methods"},{"key":"1822_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13041-014-0063-0","volume":"7","author":"B Ray","year":"2014","unstructured":"Ray B, Chopra N, Long JM, Lahiri DK. Human primary mixed brain cultures: preparation, differentiation, characterization and application to neuroscience research. Mol Brain. 2014;7:63.","journal-title":"Mol Brain"},{"key":"1822_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0736-5748(99)00036-2","volume":"17","author":"DM Kerkovich","year":"1999","unstructured":"Kerkovich DM, et al. Fetal human cortical neurons grown in culture: morphological differentiation, biochemical correlates and development of electrical activity. Int J Dev Neurosci. 1999;17:347\u201356.","journal-title":"Int J Dev Neurosci"},{"key":"1822_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0006-8993(91)91003-J","volume":"542","author":"MP Mattson","year":"1991","unstructured":"Mattson MP, Rychlik B, Song You J, Sisken JE. Sensitivity of cultured human embryonic cerebral cortical neurons to excitatory amino acid-induced calcium influx and neurotoxicity. Brain Res. 1991;542:97\u2013106.","journal-title":"Brain Res"},{"key":"1822_CR33","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","volume":"287","author":"JM Long","year":"2012","unstructured":"Long JM, Ray B, Lahiri DK. MicroRNA-153 physiologically inhibits expression of Amyloid-\u03b2 precursor protein in cultured human fetal brain cells and is dysregulated in a subset of alzheimer disease Patients *. J Biol Chem. 2012;287:31298\u2013310.","journal-title":"J Biol Chem"},{"key":"1822_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF03159951","volume":"15","author":"MP Mattson","year":"1991","unstructured":"Mattson MP, Engle MG, Rychlik B. Effects of elevated intracellular calcium levels on the cytoskeleton and Tau in cultured human cortical neurons. Mol Chem Neuropathol. 1991;15:117\u201342.","journal-title":"Mol Chem Neuropathol"},{"key":"1822_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0006-8993(90)91462-P","volume":"522","author":"MP Mattson","year":"1990","unstructured":"Mattson MP, Rychlik B. Cell culture of cryopreserved human fetal cerebral cortical and hippocampal neurons: neuronal development and responses to trophic factors. Brain Res. 1990;522:204\u201314.","journal-title":"Brain Res"},{"key":"1822_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0006-8993(88)90331-9","volume":"473","author":"V Silani","year":"1988","unstructured":"Silani V, et al. Human neuronal cell viability demonstrated in culture after cryopreservation. Brain Res. 1988;473:169\u201374.","journal-title":"Brain Res"},{"key":"1822_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","volume":"178","author":"JH Jhamandas","year":"2011","unstructured":"Jhamandas JH, et al. Actions of \u03b2-Amyloid protein on human neurons are expressed through the Amylin receptor. Am J Pathol. 2011;178:140\u20139.","journal-title":"Am J Pathol"},{"key":"1822_CR38","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1523\/JNEUROSCI.15-12-07837.1995","volume":"15","author":"A LeBlanc","year":"1995","unstructured":"LeBlanc A. Increased production of 4\u00a0kda amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J Neurosci. 1995;15:7837\u201346.","journal-title":"J Neurosci"},{"key":"1822_CR39","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/j.1471-4159.1993.tb13658.x","volume":"61","author":"J Busciglio","year":"1993","unstructured":"Busciglio J, Yeh J, Yankner BA. \u03b2-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J Neurochem. 1993;61:1565\u20138.","journal-title":"J Neurochem"},{"key":"1822_CR40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0197-4580(92)90065-6","volume":"13","author":"J Busciglio","year":"1992","unstructured":"Busciglio J, Lorenzo A, Yankner BA. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol Aging. 1992;13:609\u201312.","journal-title":"Neurobiol Aging"},{"key":"1822_CR41","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/s41380-019-0610-2","volume":"26","author":"N Chopra","year":"2021","unstructured":"Chopra N, et al. MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-converting enzyme 1 (BACE1) and specific Tau protein moieties. Mol Psychiatry. 2021;26:5636\u201357.","journal-title":"Mol Psychiatry"},{"key":"1822_CR42","doi-asserted-by":"publisher","first-page":"12676","DOI":"10.1523\/JNEUROSCI.1243-10.2010","volume":"30","author":"A Jana","year":"2010","unstructured":"Jana A, Pahan K. Fibrillar Amyloid-\u03b2-Activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for alzheimer\u2019s disease. J Neurosci. 2010;30:12676\u201389.","journal-title":"J Neurosci"},{"key":"1822_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41380-018-0266-3","volume":"24","author":"JM Long","year":"2019","unstructured":"Long JM, Maloney B, Rogers JT, Lahiri DK. Novel upregulation of amyloid-\u03b2 precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5\u2032-untranslated region: implications in alzheimer\u2019s disease. Mol Psychiatry. 2019;24:345\u201363.","journal-title":"Mol Psychiatry"},{"key":"1822_CR44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41598-020-77808-2","volume":"11","author":"FP Perez","year":"2021","unstructured":"Perez FP, Maloney B, Chopra N, Morisaki JJ, Lahiri DK. Repeated electromagnetic field stimulation lowers amyloid-\u03b2 peptide levels in primary human mixed brain tissue cultures. Sci Rep. 2021;11:621.","journal-title":"Sci Rep"},{"key":"1822_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0665-5","volume":"10","author":"B Ray","year":"2020","unstructured":"Ray B, et al. Rivastigmine modifies the \u03b1-secretase pathway and potentially early alzheimer\u2019s disease. Transl Psychiatry. 2020;10:1\u201317.","journal-title":"Transl Psychiatry"},{"key":"1822_CR46","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1523\/JNEUROSCI.23-19-07385.2003","volume":"23","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, et al. p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid \u03b2 peptide cytotoxicity. J Neurosci. 2003;23:7385\u201394.","journal-title":"J Neurosci"},{"key":"1822_CR47","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1038\/cddis.2010.74","volume":"1","author":"SN Sivananthan","year":"2010","unstructured":"Sivananthan SN, Lee AW, Goodyer CG, LeBlanc AC. Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid \u03b2-peptide-independent neuronal degeneration in primary human neuron cultures. Cell Death Dis. 2010;1:e100\u2013100.","journal-title":"Cell Death Dis"},{"key":"1822_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang J, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med. 2016;22:78\u201383.","journal-title":"Nat Med"},{"key":"1822_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","volume":"99","author":"J Pan","year":"2017","unstructured":"Pan J, et al. Inhibition of Bcl-2\/xl with ABT-263 selectively kills senescent type II pneumocytes and reverses persistent pulmonary fibrosis induced by ionizing radiation in mice. Int J Radiation Oncology*Biology*Physics. 2017;99:353\u201361.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"1822_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell. 2016;15:428\u201335.","journal-title":"Aging Cell"},{"key":"1822_CR51","unstructured":"Dorsey JF, Jove R, Kraker AJ, Wu J. The Pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells. Cancer Res 60, (2000)."},{"key":"1822_CR52","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1021\/jm049486a","volume":"47","author":"LJ Lombardo","year":"2004","unstructured":"Lombardo LJ, et al. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual src\/abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem. 2004;47:6658\u201361.","journal-title":"J Med Chem"},{"key":"1822_CR53","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1093\/jn\/136.11.2715","volume":"136","author":"AB Granado-Serrano","year":"2006","unstructured":"Granado-Serrano AB, Marti\u00edn MA, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and Inhibition of PI-3-kinase\/Akt and ERK pathways in a human hepatoma cell line (HepG2. J Nutr. 2006;136:2715\u201321.","journal-title":"J Nutr"},{"key":"1822_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.canlet.2008.03.046","volume":"269","author":"A Murakami","year":"2008","unstructured":"Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by Quercetin. Cancer Lett. 2008;269:315\u201325.","journal-title":"Cancer Lett"},{"key":"1822_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12979-020-00187-9","volume":"17","author":"A Kale","year":"2020","unstructured":"Kale A, Sharma A, Stolzing A, Desprez P-Y, Campisi J. Role of immune cells in the removal of deleterious senescent cells. Immun Ageing. 2020;17:16.","journal-title":"Immun Ageing"},{"key":"1822_CR56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.100897","volume":"8","author":"A Sagiv","year":"2016","unstructured":"Sagiv A, et al. NKG2D ligands mediate immunosurveillance of senescent cells. Aging. 2016;8:328\u201344.","journal-title":"Aging"},{"key":"1822_CR57","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/nprot.2006.356","volume":"1","author":"S Kaech","year":"2006","unstructured":"Kaech S, Banker G. Culturing hippocampal neurons. Nat Protoc. 2006;1:2406\u201315.","journal-title":"Nat Protoc"},{"key":"1822_CR58","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/biom11091361","volume":"11","author":"AM Jurga","year":"2021","unstructured":"Jurga AM, Paleczna M, Kadluczka J, Kuter K. Z. Beyond the GFAP-Astrocyte protein markers in the brain. Biomolecules. 2021;11:1361.","journal-title":"Biomolecules"},{"key":"1822_CR59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrn2852","volume":"11","author":"MN Rasband","year":"2010","unstructured":"Rasband MN. The axon initial segment and the maintenance of neuronal Polarity. Nat Rev Neurosci. 2010;11:552\u201362.","journal-title":"Nat Rev Neurosci"},{"key":"1822_CR60","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME. Visualization of neurofibrillary tangle maturity in alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research. Alzheimer\u2019s Dement. 2021;17:1554\u201374.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1822_CR61","doi-asserted-by":"crossref","unstructured":"Wischik CM et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proceedings of the National Academy of Sciences 85, 4506\u20134510 (1988).","DOI":"10.1073\/pnas.85.12.4506"},{"key":"1822_CR62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC\u20101, a new monoclonal antibody Raised to paired helical filaments, recognize conformational epitopes on Recombinant Tau. J Neurosci Res. 1997;48:128\u201332.","journal-title":"J Neurosci Res"},{"key":"1822_CR63","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1002\/cpz1.32","volume":"1","author":"F Neri","year":"2021","unstructured":"Neri F, Basisty N, Desprez P, Campisi J, Schilling B. Quantitative proteomic analysis of the Senescence-Associated secretory phenotype by Data\u2010Independent acquisition. Curr Protoc. 2021;1:e32.","journal-title":"Curr Protoc"},{"key":"1822_CR64","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"J-P Copp\u00e9","year":"2008","unstructured":"Copp\u00e9 J-P, et al. Senescence-Associated secretory phenotypes reveal Cell-Nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:e301.","journal-title":"PLoS Biol"},{"key":"1822_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2007-8-2-206","volume":"8","author":"Y Shiraishi-Yamaguchi","year":"2007","unstructured":"Shiraishi-Yamaguchi Y, Furuichi T. The Homer family proteins. Genome Biol. 2007;8:1\u201312.","journal-title":"Genome Biol"},{"key":"1822_CR66","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrn1370","volume":"5","author":"NE Ziv","year":"2004","unstructured":"Ziv NE, Garner CC. Cellular and molecular mechanisms of presynaptic assembly. Nat Rev Neurosci. 2004;5:385\u201399.","journal-title":"Nat Rev Neurosci"},{"key":"1822_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-016-0139-7","volume":"11","author":"SH Choi","year":"2016","unstructured":"Choi SH, Kim YH, Quinti L, Tanzi RE, Kim D. Y. 3D culture models of alzheimer\u2019s disease: a road map to a cure-in-a-dish. Mol Neurodegeneration. 2016;11:75.","journal-title":"Mol Neurodegeneration"},{"key":"1822_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-2-18","volume":"2","author":"R Kayed","year":"2007","unstructured":"Kayed R, et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegeneration. 2007;2:18.","journal-title":"Mol Neurodegeneration"},{"key":"1822_CR69","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.201206006","volume":"201","author":"AR Davalos","year":"2013","unstructured":"Davalos AR, et al. p53-dependent release of alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol. 2013;201:613\u201329.","journal-title":"J Cell Biol"},{"key":"1822_CR70","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1091\/mbc.e11-10-0884","volume":"23","author":"A Freund","year":"2012","unstructured":"Freund A, Laberge R-M, Demaria M, Campisi J. Lamin B1 loss is a senescence-associated biomarker. MBoC. 2012;23:2066\u201375.","journal-title":"MBoC"},{"key":"1822_CR71","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1101\/gad.179515.111","volume":"25","author":"T Shimi","year":"2011","unstructured":"Shimi T, et al. The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev. 2011;25:2579\u201393.","journal-title":"Genes Dev"},{"key":"1822_CR72","doi-asserted-by":"crossref","unstructured":"Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Apoptosis Cancer: Methods Protocols 13\u201321 (2008).","DOI":"10.1007\/978-1-59745-339-4_2"},{"key":"1822_CR73","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1083\/jcb.151.5.951","volume":"151","author":"L Faleiro","year":"2000","unstructured":"Faleiro L, Lazebnik Y. Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol. 2000;151:951\u201360.","journal-title":"J Cell Biol"},{"key":"1822_CR74","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1074\/jbc.C400538200","volume":"280","author":"S Kamada","year":"2005","unstructured":"Kamada S, Kikkawa U, Tsujimoto Y, Hunter T. Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein (s. J Biol Chem. 2005;280:857\u201360.","journal-title":"J Biol Chem"},{"key":"1822_CR75","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","volume":"187","author":"M Ogrodnik","year":"2024","unstructured":"Ogrodnik M, et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell. 2024;187:4150\u201375.","journal-title":"Cell"},{"key":"1822_CR76","doi-asserted-by":"crossref","unstructured":"Unknown fates of (brain) oxidation or UFO: close encounters with neuronal senescence. Free Radic Biol Med 134, 695\u2013701 (2019).","DOI":"10.1016\/j.freeradbiomed.2019.01.012"},{"key":"1822_CR77","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci. 1995;92:9363\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1822_CR78","doi-asserted-by":"publisher","first-page":"623175","DOI":"10.3389\/fcell.2021.623175","volume":"9","author":"JA Mera-Rodr\u00edguez","year":"2021","unstructured":"Mera-Rodr\u00edguez JA, et al. Is senescence-associated \u03b2-galactosidase a reliable in vivo marker of cellular senescence during embryonic development? Front Cell Dev Biology. 2021;9:623175.","journal-title":"Front Cell Dev Biology"},{"key":"1822_CR79","doi-asserted-by":"publisher","first-page":"81099","DOI":"10.18632\/oncotarget.12752","volume":"7","author":"M Piechota","year":"2016","unstructured":"Piechota M, et al. Is senescence-associated \u03b2-galactosidase a marker of neuronal senescence? Oncotarget. 2016;7:81099.","journal-title":"Oncotarget"},{"key":"1822_CR80","doi-asserted-by":"publisher","first-page":"e13296","DOI":"10.1111\/acel.13296","volume":"20","author":"M Ogrodnik","year":"2021","unstructured":"Ogrodnik M, et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell. 2021;20:e13296.","journal-title":"Aging Cell"},{"key":"1822_CR81","doi-asserted-by":"publisher","first-page":"e13521","DOI":"10.1111\/acel.13521","volume":"21","author":"I Matias","year":"2022","unstructured":"Matias I, et al. Loss of lamin-B1 and defective nuclear morphology are hallmarks of astrocyte senescence in vitro and in the aging human hippocampus. Aging Cell. 2022;21:e13521.","journal-title":"Aging Cell"},{"key":"1822_CR82","doi-asserted-by":"crossref","unstructured":"Gaikwad S et al. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to alzheimer\u2019s disease and frontotemporal dementia. Cell Rep 36, (2021).","DOI":"10.1016\/j.celrep.2021.109419"},{"key":"1822_CR83","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1101\/gad.223834.113","volume":"27","author":"PP Shah","year":"2013","unstructured":"Shah PP, et al. Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev. 2013;27:1787\u201399.","journal-title":"Genes Dev"},{"key":"1822_CR84","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou Z, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017;550:402\u20136.","journal-title":"Nature"},{"key":"1822_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrm3488","volume":"14","author":"B Burke","year":"2013","unstructured":"Burke B, Stewart CL. The nuclear lamins: flexibility in function. Nat Rev Mol Cell Biol. 2013;14:13\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1822_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331\u201342.","journal-title":"Nat Rev Immunol"},{"key":"1822_CR87","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"YI Zhu","year":"2015","unstructured":"Zhu YI, et al. The achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14:644\u201358.","journal-title":"Aging Cell"},{"key":"1822_CR88","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1073\/pnas.87.22.9020","volume":"87","author":"BA Yankner","year":"1990","unstructured":"Yankner BA, Caceres A, Duffy LK. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci. 1990;87:9020\u20133.","journal-title":"Proc Natl Acad Sci"},{"key":"1822_CR89","doi-asserted-by":"crossref","unstructured":"Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and Neurotoxic Effects of Amyloid,8 Protein: Reversal by Tachykinin Neuropeptides. 250.","DOI":"10.1126\/science.2218531"},{"key":"1822_CR90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000111270","volume":"17","author":"R Bowser","year":"2010","unstructured":"Bowser R, Giambrone A, Davies P. FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain (Part 1 of 2). Dev Neurosci. 2010;17:20\u20139.","journal-title":"Dev Neurosci"},{"key":"1822_CR91","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody Raised to paired helical filaments, recognize conformational epitopes on Recombinant Tau. J Neurosci Res. 1997;48:128\u201332.","journal-title":"J Neurosci Res"},{"key":"1822_CR92","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.3083509","volume":"232","author":"BL Wolozin","year":"1986","unstructured":"Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of alzheimer patients. Science. 1986;232:648\u201350.","journal-title":"Science"},{"key":"1822_CR93","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0896-6273(90)90447-N","volume":"4","author":"MP Mattson","year":"1990","unstructured":"Mattson MP. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2\u2009+\u2009influx in cultured hippocampal neurons. Neuron. 1990;4:105\u201317.","journal-title":"Neuron"},{"key":"1822_CR94","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","volume":"29","author":"MM Gonzales","year":"2023","unstructured":"Gonzales MM, et al. Senolytic therapy in mild alzheimer\u2019s disease: a phase 1 feasibility trial. Nat Med. 2023;29:2481\u20138.","journal-title":"Nat Med"},{"key":"1822_CR95","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ni.3666","volume":"18","author":"B Engelhardt","year":"2017","unstructured":"Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017;18:123\u201331.","journal-title":"Nat Immunol"},{"key":"1822_CR96","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/NEN.0b013e3181772cf6","volume":"67","author":"PJ Darlington","year":"2008","unstructured":"Darlington PJ, et al. Innate immune-mediated neuronal injury consequent to loss of astrocytes. J Neuropathology Experimental Neurol. 2008;67:590\u20139.","journal-title":"J Neuropathology Experimental Neurol"},{"key":"1822_CR97","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41420-024-01976-7","volume":"10","author":"Y Deng","year":"2024","unstructured":"Deng Y, et al. Targeting senescent cells with NKG2D-CAR T cells. Cell Death Discovery. 2024;10:217.","journal-title":"Cell Death Discovery"},{"key":"1822_CR98","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1126\/scitranslmed.add1951","volume":"15","author":"D Yang","year":"2023","unstructured":"Yang D, et al. NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates. Sci Transl Med. 2023;15:1951.","journal-title":"Sci Transl Med"},{"key":"1822_CR99","doi-asserted-by":"crossref","unstructured":"Greenberg EF et al. Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates. Heliyon 10, (2024).","DOI":"10.1016\/j.heliyon.2024.e36483"},{"key":"1822_CR100","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","volume":"14","author":"H Zhang","year":"2007","unstructured":"Zhang H, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ. 2007;14:943\u201351.","journal-title":"Cell Death Differ"},{"key":"1822_CR101","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason KD, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128:1173\u201386.","journal-title":"Cell"},{"key":"1822_CR102","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1182\/blood.V108.11.1107.1107","volume":"108","author":"AR Shoemaker","year":"2006","unstructured":"Shoemaker AR, et al. The Bcl-2 family inhibitor ABT-263 shows significant but reversible thrombocytopenia in mice. Blood. 2006;108:1107.","journal-title":"Blood"},{"key":"1822_CR103","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers AJ, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19:202\u20138.","journal-title":"Nat Med"},{"key":"1822_CR104","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline EN, Bicca MA, Viola KL, Klein WL. The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade. J Alzheimer\u2019s Disease. 2018;64:567\u2013610.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"1822_CR105","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul S, Lal G. The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol. 2017;8:1124.","journal-title":"Front Immunol"},{"key":"1822_CR106","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00262-015-1761-x","volume":"65","author":"G Suck","year":"2016","unstructured":"Suck G, et al. NK-92: an \u2018off-the-shelf therapeutic\u2019for adoptive natural killer cell-based cancer immunotherapy. Cancer Immunol Immunother. 2016;65:485\u201392.","journal-title":"Cancer Immunol Immunother"},{"key":"1822_CR107","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119:7\u201335.","journal-title":"Acta Neuropathol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01822-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:08:42Z","timestamp":1757308122000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01822-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01822-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.28.635165","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research utilized de-identified primary neurons commercially obtained from ScienCell. ScienCell acquires human tissues from non-profit tissue providers who certify that all specimens are procured in accordance with local, state, and federal regulations governing the ethical collection and distribution of human biological materials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}